MAPT and Alzheimer disease: We might have expected lower Aβ1-42/Aβ1-40 ratio and Aβ1-42 and/or higher P-tau181 and T-Tau levels in our AD patients with SEA, given the role of Aβ and tau in inducing neuronal hyperactivity [6].